Lili Zhang

Lili Zhang, M.D. is a physician scientist at Montefiore Medical Center specializing in the intersection of cardiology and oncology. Her work focuses on understanding and managing cardiac complications associated with cancer therapies, with particular expertise in cardiotoxicity assessment and prevention.

Dr. Zhang's research interests center on cardio-oncology, with specific focus on immune checkpoint inhibitor myocarditis, anthracycline cardiotoxicity, and cardiac complications of emerging cancer therapies like CAR-T cell therapy. Her work integrates clinical cardiology with oncology to develop better monitoring strategies and protective interventions for cancer patients at risk of cardiovascular complications. She employs multimodal imaging techniques to detect early cardiac changes in patients undergoing cancer treatment.

Analysis of Dr. Zhang's recent publications reveals a strong focus on the rapidly evolving field of cardio-oncology, with particular attention to newer cancer therapies and their cardiac implications. Her work spans from basic mechanisms of cardiotoxicity to clinical management strategies, with an increasing emphasis on health disparities and social determinants of health in cardio-oncology outcomes.

Dr. Zhang maintains an active research program with numerous publications in high-impact cardiology and oncology journals. Her collaborative network includes researchers across cardiology, oncology, and imaging specialties, reflecting the interdisciplinary nature of cardio-oncology research.